![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Quinn Bridget A Dash Rupesh Azab Belal Sarkar Siddik Das Swadesh K Kumar Sachin Oyesanya Regina A Dasgupta Santanu Dent Paul Grant Steven Rahmani Mohamed Curiel David T Dmitriev Igor Hedvat Michael Wei Jun Wu Bainan Stebbins John L Reed John C Pellecchia Maurizio Sarkar Devanand Fisher Paul B
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.20, Iss.10, 2011-10, pp. : 1397-1411
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cancer Therapy By Targeting Hypoxia-Inducible Factor-1
Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting survivin in cancer therapy
By Pennati Marzia Folini Marco Zaffaroni Nadia
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 4, 2008-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting SP1 Transcription Factor in Prostate Cancer Therapy
Medicinal Chemistry, Vol. 7, Iss. 5, 2011-09 ,pp. :